Noritren Tafla 50 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

noritren tafla 50 mg

h. lundbeck a/s* - nortriptylinum hýdróklóríð - tafla - 50 mg

Enteroporc Coli AC Evrópusambandið - íslenska - EMA (European Medicines Agency)

enteroporc coli ac

ceva santé animale - clostridium perfringens type c, beta1 toxoid / clostridium perfringens, type a, alpha toxoid / clostridium perfringens, type a, beta2 toxoid / escherichia coli, fimbrial adhesin f4ab / escherichia coli, fimbrial adhesin f4ac / escherichia coli, fimbrial adhesin f5 / escherichia coli, fimbrial adhesin f6 - immunologicals for suidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) escherichia + clostridium - svín - for the passive immunisation of progeny by active immunisation of pregnant sows and gilts to reduce:-           clinical signs (severe diarrhoea) and mortality caused by escherichia coli strains expressing the fimbrial adhesins f4ab, f4ac, f5 and f6-           clinical signs (diarrhoea during the first days of life) associated with clostridium perfringens type a expressing alpha and beta 2 toxins-           clinical signs and mortality associated with haemorrhagic and necrotising enteritis caused by clostridium perfringens type c expressing beta1 toxin.

Haldol Tafla 1 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

haldol tafla 1 mg

essential pharma limited - haloperidolum inn - tafla - 1 mg

Hydromed Tafla 25 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

hydromed tafla 25 mg

medilink a/s - hydrochlorothiazidum inn - tafla - 25 mg

Hydromed Tafla 12,5 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

hydromed tafla 12,5 mg

medilink a/s - hydrochlorothiazidum inn - tafla - 12,5 mg

Nplate Evrópusambandið - íslenska - EMA (European Medicines Agency)

nplate

amgen europe b.v. - romiplostim - purpura, blóðflagnafæð, blóðflagnafæð - antihemorrhagics - adults:nplate is indicated for the treatment of primary immune thrombocytopenia  (itp) in adult patients who are refractory to other treatments (e. barkstera, immúnóglóbúlín). paediatrics:nplate is indicated for the treatment of chronic primary immune thrombocytopenia (itp) in paediatric patients one year of age and older who are refractory to other treatments (e. barkstera, immúnóglóbúlín).

Seloken ZOC Forðatafla 95 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

seloken zoc forðatafla 95 mg

recordati ireland limited* - metoprololum súkkínat - forðatafla - 95 mg

Seloken ZOC Forðatafla 47,5 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

seloken zoc forðatafla 47,5 mg

recordati ireland limited* - metoprololum súkkínat - forðatafla - 47,5 mg

Seloken ZOC Forðatafla 23,75 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

seloken zoc forðatafla 23,75 mg

recordati ireland limited* - metoprololum súkkínat - forðatafla - 23,75 mg

Seloken ZOC Forðatafla 190 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

seloken zoc forðatafla 190 mg

recordati ireland limited* - metoprololum súkkínat - forðatafla - 190 mg